Fatty liver disease is no longer just about being overweight, and doctors have renamed it to reflect a deeper truth: it's fundamentally a metabolic problem. In 2023, the medical community shifted from calling it nonalcoholic fatty liver disease (NAFLD) to metabolic dysfunction-associated steatotic liver disease (MASLD), a change designed to emphasize the metabolic underpinnings of the disease and to use nonstigmatizing language . This isn't just a semantic shift; it signals a major rethinking of how we understand and treat one of the most common liver conditions affecting millions of Americans.

What Exactly Is Metabolic Dysfunction-Associated Steatotic Liver Disease?

MASLD is defined as the accumulation of fat in liver cells when at least one cardiometabolic risk factor is present . Unlike the old terminology, which implied the condition only affected people who didn't drink alcohol, the new name acknowledges that metabolic dysfunction is the real driver. The condition develops when your body struggles to manage lipids, glucose, and inflammation in ways that go far beyond simple weight gain.

The cardiometabolic risk factors that define MASLD include :

• Obesity or increased waist circumference: Excess body fat, particularly around the abdomen, disrupts how your body processes fats and glucose.
• Impaired fasting glucose or type 2 diabetes: When your blood sugar regulation fails, your liver accumulates fat more readily.
• Hypertension: High blood pressure often coexists with the metabolic dysfunction that drives liver fat accumulation.
• Hypertriglyceridemia: Elevated triglycerides in your blood signal that your body is struggling to process fats efficiently.
• Low HDL cholesterol: Low levels of "good" cholesterol reflect broader metabolic imbalance.

How Common Is This Condition, and Is It Getting Worse?

The prevalence of MASLD has risen dramatically over the past three decades, mirroring increases in obesity and type 2 diabetes. Current estimates indicate that MASLD affects approximately 34 to 38 percent of the adult population in the United States . That means roughly one in three American adults has some degree of fat accumulation in their liver. The outlook is even more concerning: longitudinal modeling suggests that prevalence will exceed 40 percent by 2050, affecting more than 120 million individuals .

Within the MASLD spectrum, there's a more severe form called metabolic dysfunction-associated steatohepatitis (MASH), which involves not just fat accumulation but also inflammation and hepatocyte injury. MASH is estimated to affect approximately 5.8 percent of the population today, with projections rising to 7.9 percent by 2050 . MASH is a progressive condition that may lead to advanced fibrosis, cirrhosis, and hepatocellular carcinoma .

Why Does Your Liver Accumulate Fat in the First Place?

The pathophysiology of MASLD involves complex interactions between genetic predisposition and metabolic dysfunction. The primary mechanisms include an increase in hepatic free fatty acid delivery from adipose tissue, enhanced de novo lipogenesis (the creation of new fat within the liver), and impaired mitochondrial fatty acid beta oxidation, which is your cells' ability to burn fat for energy . Additionally, a deficiency in the incorporation or export of triglycerides as very low density lipoprotein (VLDL) can lead to further lipid retention within liver cells .

Insulin resistance sits at the center of this metabolic dysregulation. When your cells become resistant to insulin, your body responds by producing more insulin, which stimulates a key transcription factor called SREBP-1c that upregulates de novo lipogenesis. In other words, high insulin levels tell your liver to make more fat . Meanwhile, your liver struggles to export the triglycerides it produces, so they accumulate inside hepatocytes.

What Role Does Alcohol Play in This New Classification?

The medical community also created a new category called metabolic dysfunction-associated steatotic liver disease with increased alcohol intake (MetALD) to describe individuals who meet the criteria for MASLD but also consume significant amounts of alcohol . For women, this threshold is 20 to 50 grams per day; for men, it's 30 to 60 grams per day . Data from 2026 report the prevalence of MetALD at 4.10 percent within the United States .

Notably, individuals with MetALD or alcohol-associated liver disease (ALD) who also have type 2 diabetes or engage in binge drinking face significantly higher risks of premature mortality compared to those with MASLD alone . This underscores why the new terminology matters: it helps clinicians identify patients at highest risk and tailor interventions accordingly.

How Can You Detect MASLD Early?

One of the most important markers for detecting liver stress is alanine aminotransferase (ALT), an enzyme found primarily inside liver cells . Under normal conditions, ALT stays inside liver cells, and only small amounts circulate in the bloodstream. However, when liver cells become damaged or stressed, ALT leaks into the blood, making it a sensitive marker of liver injury .

ALT levels above approximately 35 to 45 U/L (depending on the lab) may indicate liver stress or damage . Mild elevations are often linked to metabolic dysfunction, even before a formal diagnosis is made, which is why ALT can be an early warning sign . The good news is that ALT is highly responsive to lifestyle changes, making it a powerful tool for prevention.

Steps to Support Your Liver Health Through Lifestyle Changes

• Focus on whole, anti-inflammatory foods: Eliminate or drastically reduce processed foods and refined sugars, which drive insulin resistance and hepatic fat accumulation. Prioritize vegetables, whole grains, legumes, and lean proteins.
• Reduce sugar and processed carbohydrates: These foods spike blood glucose and insulin levels, directly promoting de novo lipogenesis in your liver. Swap refined carbs for fiber-rich alternatives.
• Increase fiber and healthy fats: Soluble fiber helps regulate glucose absorption, while healthy fats from sources like olive oil, nuts, and fatty fish support metabolic health and reduce inflammation.
• Improve insulin sensitivity through exercise: Regular physical activity enhances your cells' ability to respond to insulin and promotes mitochondrial fat oxidation, helping your liver burn rather than store fat.
• Maintain a healthy weight: Even modest weight loss can significantly reduce hepatic steatosis and improve liver enzyme levels.
• Limit alcohol intake: If you consume alcohol, stay well below the thresholds that define MetALD to avoid compounding metabolic liver injury.

Why Should You Care About the Name Change?

The shift from NAFLD to MASLD represents a fundamental change in how the medical community understands liver disease. By emphasizing metabolic dysfunction rather than weight alone, the new terminology helps patients and clinicians recognize that this condition is rooted in how your body processes energy, glucose, and fats. It's not a moral failing or a simple matter of eating less; it's a complex interplay of genetics, metabolism, and lifestyle factors.

This reframing also opens the door to more targeted interventions. Rather than generic weight loss advice, clinicians can now focus on addressing insulin resistance, reducing inflammation, and optimizing metabolic health. For patients, it means understanding that even if you're lean, you can still develop MASLD if you have metabolic risk factors like insulin resistance or dyslipidemia .

The bottom line: if you have any of the five cardiometabolic risk factors, getting your ALT checked and discussing your metabolic health with your healthcare provider is a smart move. Early detection and lifestyle intervention can prevent progression to MASH, fibrosis, and cirrhosis, making prevention far more effective than treating advanced disease.